FDA Brief

Warning letters Drugs

FDA warning letter to

Simex Logistics S.A. de C.V.

High riskIssued Jan 28, 2021Posted Feb 9, 2021Center for Drug Evaluation and Research | CDER

Mexican drugmaker Simex Logistics shipped hand sanitizer labeled 70% alcohol that tested at 51%, FDA says.

What happened

FDA tested a batch (lot 0720) of HEALTH & HAND GEL HAND SANITIZER that was held at the U.S. border and found 51% ethanol by volume instead of the 70% stated on the label. In an October 7, 2020 call, the firm said it had released at least two lots without testing the finished product and used an in-house refractometer test FDA calls unsuitable, with no microbial testing; the firm recalled all its hand sanitizers on November 25, 2020, and FDA placed all its drugs on Import Alert 66-78, which lets FDA block shipments at the border without examining them.

What FDA found

  1. The hand sanitizer was labeled 70% alcohol but tested at 51%, making it weaker than claimed; FDA calls such a product adulterated, meaning it fails the strength or quality it says it has.

    FD&C Act section 501(c), 21 U.S.C. 351(c)
  2. The company shipped at least two lots to the U.S. market without testing the finished product before release.

    21 CFR 211.165
  3. Its in-house test used a refractometer, a device FDA says does not work for hand sanitizers that contain ingredients other than alcohol and water, and the firm did no testing for harmful microbes.

    21 CFR 211.165 and 211.100
  4. The product is an unapproved new drug: it is sold without FDA approval and does not meet the conditions that allow hand sanitizers on the market without one.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  5. The 70% alcohol claim on the label is false and misleading because the product contains less than that.

    FD&C Act section 502(a), 21 U.S.C. 352(a)
  6. The product is misbranded because it is a nonprescription drug that does not comply with the rules for marketing under section 505G of the Act.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee)

What FDA wants

FDA tells the firm to reply in writing within 15 working days with plans to reformulate the product, strengthen quality oversight, validate its manufacturing processes and equipment, and list the chemical and microbial test methods used before each lot is released. FDA also strongly recommends hiring a qualified consultant in current good manufacturing practice (CGMP), FDA's required quality standards for drug production.

Who should pay attention

  • brands and distributors that buy hand sanitizer from contract manufacturers in Mexico
  • retailers and importers sourcing over-the-counter antiseptic drugs
  • U.S. agents and consultants representing foreign drug manufacturers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Macau-Union Pharmaceutical Limited

    Macau-Union Pharmaceutical failed CGMP and sold unapproved, misbranded Bamboo Pharmacy OTC pain rubs in the U.S.

    High risk
  2. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  3. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  4. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk